RxDoctor Payments Data

Kenya Blake Codrington

Neonatal · Laurel, MDNPI 1750940466

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,197 of the $2,573 with a category attached, or 85.4%. It is spread thinly across 18 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations. Among neonatal clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,573in general payments, 2019–2025

Across 48 payments — averaging $53.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$554
  • AbbVie$364
  • Johnson & Johnson$296
  • AstraZeneca$277
  • Lilly USA, LLC$248
  • Astellas Pharma US Inc$176
  • plus $658 from 12 others

What the payments were for

  • Food & beverage$2,19785%
  • Education$37615%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,573 in reported general payments places this provider in the 95th percentile of 26 neonatal providers in Maryland.

See all neonatal providers in Maryland

Medicare billing

Part B allowed, 2024
$30,924
Medicare patients
192
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate11$244

Paid to pharmacies, not to this prescriber.

Other neonatal in Laurel

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →